NAVIGATING GLOBAL EXCELLENCE DUBAI’S COMPASS IN HEALTH SERVICES DUPHAT 2024

0

Concludes in Dubai with Business Deals Worth 8.5 Billion AED

The deals sealed during DUPHAT 2024 stand as testament to the substantial ambitions driving the pharmacy and technology sector in Dubai and the surrounding region.

The activities of the 29th edition of the Dubai International Pharmacy Technologies Conference and Exhibition – DUPHAT 2024, concluded in Dubai today with unparalleled success which reflected in the volume of direct and indirect commercial deals that were generated over the course of three days. The value amounted to over 8.5 billion AED.

Dr. Ali Al Sayed Hussain, Chairman of DUPHAT stated: “Through DUPHAT, we endeavor to economically and academically support the pharmaceutical industry by cultivating partnerships among stakeholders and professionals within this sector.”

DUPHAT is a very focused pharmaceutical show exhibiting the new innovative brands, generics, bio similars and a wonderful umbrella for pharmaceutical companies to show case their strengths. Moreover it’s a very unique opportunity for regional distributors to collaborate for the brands in their countries. Pharma solutions has been exhibiting regularly in DUPHAT since 6 years and have gained an access to regional distribution partners. Moreover it has been an excellent networking platform with industry peers and healthcare fraternity

Khursheed Zaidi
Chairman – Pharma Solutions

Economic Aspect DUPHAT 2024 stands as a pivotal cornerstone in fortifying the UAE economy. This significant event plays a substantial role in bolstering both the retail and tourism sectors within the country and the broader region, owing to the diverse array of participants and visitors hailing from across the globe. DUPHAT actively contributes to fostering trade promotion and the amalgamation of ideas and innovations, thereby revitalizing the public economy. This positive influence amplifies business potential, aligning seamlessly with the UAE’s vision of being a premier destination for commerce and tourism. It mirrors the dynamic interaction among participants, propelling economic progress forward.

His Excellency Ambassador Dr. AbdulSalam AlMadani, Executive Chairman of DUPHAT:” commented on the tremendous success of DUPHAT this year: “We remain steadfast in our pursuit of the visionary leadership of the UAE that has achieved unprecedented creativity and distinction in the health sector, setting unparalleled standards for Dubai that we are unwaveringly committed to upholding.”

H.E. Amb. Dr. AbdulSalam AlMadani stated that the value of the trade deals concluded over the past three days amounted to AED 8.5 billion in DUPHAT this year, and the most prominent deals concluded. He added: “The deals achieved in DUPHAT are a testament to the great ambition of the pharmacy and technology industry as well as placing Dubai in the Global City Strength Index.”

We remain steadfast in our pursuit of the visionary leadership of the UAE that has achieved unprecedented creativity and distinction in the health sector, setting unparalleled standards for Dubai that we are unwaveringly committed to upholding.

HE Ambassador Dr. AbdulSalam AlMadani
Executive Chairman of DUPHAT

Shining a spotlight on the pharmaceutical industry, he added, “Every local and international company involved has affirmed their eagerness to partake in the upcoming editions, driven by the remarkable success experienced in DUPHAT this year. The event facilitated consequential deals and meetings, connecting participants with customers, suppliers, and manufacturers in the realms of pharmaceuticals and technology. This positive outcome has spurred their commitment to ensure their presence in the forthcoming year.”

The closing ceremony awarded the fostering poster presenters for their research, and the stand designs creativity and efforts made to highlight new technologies in the pharmaceutical industry.

Dubai’s prominence in the global health sector distinctly embodies the unique and paramount importance accorded to the healthcare industry in the vision of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai. His insightful perspective guides the future health visions for Dubai, outlining the envisioned trajectory and its significance.

DHA: More than 14,000 medicines coded under Dubai Drug Code

Dubai Health Authority (DHA) has announced that it has coded over 14,000 medicines in the UAE using the Dubai Drug Code (DDC), which was launched by the Authority 3 years ago. This coding aligns with the latest international technologies and standards, supporting the DHA’s future efforts to achieve optimal health sustainability.

DHA announced this at the ongoing Dubai International Pharmaceutical and Technology Conference and Exhibition (DUPHAT).

Through DUPHAT, we endeavor to economically and academically support the pharmaceutical industry by cultivating partnerships among stakeholders and professionals within this sector.

Dr. Ali Al Sayed Hussain
Chairman of DUPHAT

Saleh Al Hashimi, CEO of Dubai Health Insurance Corporation at the Authority, stated, “The Dubai Drug Code (DDC) aims to sustain the availability of medicines and pharmaceuticals, enhance patient access, and provide high accuracy in monitoring and studying future needs. This system is crucial not only for the Authority but for the entire health sector in Dubai.”

The Dubai Drug Code (DDC) List is a comprehensive list of all drugs that are registered with DHA’s Pharmacy Services department. Each registered drug is assigned a unique DDC code allowing for differentiation between drugs as per the DDC structure which includes details such as route of administration (ROA), dosage, form, pack size, price, manufacturer, registered owner and source. This system enhances patients’ access to their medicines and prevents the presence of counterfeit medication in the local pharmaceutical market.

He added, “The Tarmeez system also aims to enhance the DHA’s ability to implement and manage drug policy and economics. It facilitates the flow of pharmaceutical information, enhances transparency and competition in selecting various pharmaceutical care products, improves pharmaceutical quality rates for facilities and healthcare providers, and ensures that patients receive high-quality medicines. Additionally, it contributes to controlling the pharmaceutical market in the country, preventing manipulation of quality and prices, and strengthening the pricing rules of the Ministry of Health and Prevention.”

Al Hashimi emphasised that the “Tarmeez” system also prevents potential waste in the dispensing or use of medicines by determining the actual needs of medical facilities. In addition, it assesses the level of utilisation of each item disbursed, whether it is supplies or medicines. This will help in efficient management of resources and reduce unnecessary waste.

DUPHAT is organised annually by INDEX Conferences and Exhibitions – a member of INDEX Holding, and is supported by Dubai Health Authority, American Society of Health[1]System Pharmacists, International Society for Pharmacoepidemiology, European Federation for Pharmaceutical Sciences, European Society of Clinical Pharmacy, Society of Hospital Pharmacists of Australia and the European Society of Oncology Pharmacy.

Leave A Reply

Your email address will not be published.